Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000650219 | SCV000772056 | likely pathogenic | Developmental and epileptic encephalopathy, 1; Autosomal recessive spinocerebellar ataxia 12 | 2022-02-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with WWOX-related conditions. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the C-terminus of the WWOX protein. Other variant(s) that disrupt this region (p.Gly372*, p.Gln354*) have been observed in individuals with WWOX-related conditions (PMID: 29390993; Invitae). This suggests that this may be a clinically significant region of the protein. This variant is a gross deletion of the genomic region encompassing exon(s) 8 of the WWOX gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. |